Senators Glynn, Feighan and others referred to the investigation of pharmaceutical companies. I will sound a note of caution as I do not wish to mislead the House in any way. I commissioned Mr. Paul Gardiner, senior counsel, to undertake a study on this matter. He has now completed his report, a copy of which I have sent to the Irish Haemophilia Society for its perusal. There are issues involved which, obviously, would impact on an inquiry. We are committed to pursuing the pharmaceutical issue but in so doing we would be moving into extra-jurisdictional territory involving profound legal issues. Senators will be aware that there are difficulties involved but, notwithstanding that, we intend to pursue the matter in consultation with the Irish Haemophilia Society.